HHTM

KITCHENER, ONTARIO – Today, AHead Simulations, a leader in innovative healthcare training solutions, proudly announces the release of the CARL Pro Mega Update, a groundbreaking advancement in audiology simulation technology. This comprehensive update, the result of over two years of meticulous research, validation, testing, and development, enhances CARL’s capabilities, positioning it as a truly end-to-end workflow training platform for hearing

MILAN, ITALY– Amplifon, the global leader in hearing care services and solutions, has achieved a significant milestone by obtaining a ‘Score B’ (Full Management) in the CDP (Carbon Disclosure Project) Climate Change 2023 questionnaire for climate-conscious companies. This marks the first time the company has received such recognition, underscoring its commitment to climate-conscious practices. The CDP ranking identifies companies dedicated

EDEN PRAIRIE, MINNESOTA – Grason Stadler (GSI), a leader of clinical instrumentation, has announced new updates to the GSI AudioStar Pro™. The latest updates include the addition of the highly anticipated ACT™ Test. The Audible Contrast Threshold, or ACT, predicts your patient’s aided speech-in-noise ability and when compared to normative data can guide the clinician with hearing aid fittings. The

LYNGE, DENMARK — WS Audiology today reported strong financial results for the first quarter of its 2023/24 fiscal year. The company posted 13% organic revenue growth to 654 million euros ($700 million USD) for the three months ending December 31, 2023. This corresponded to a reported EBITDA (earnings before interest, taxes, depreciation and amortization) margin of 20.2%. The robust performance

BALLERUP, DENMARK – GN today announces the expansion of its ReSound Nexia family, giving more options for people with hearing loss to benefit from advanced hearing technology while joining the “next era” of Bluetooth connectivity. The ReSound Nexia portfolio is top-rated for hearing in noise,1 delivering exceptional speech understanding in noisy environments,2 while also providing industry-leading access to and awareness

CHICAGO, ILLINOIS — Beltone announced the expansion of its Beltone Serene™ hearing aid technology this week, to cater to a wider audience with diverse hearing needs. Beltone Serene now offers an array of popular styles to accommodate various preferences, backed by features designed to optimize hearing in any environment while embracing advanced Bluetooth® connectivity. With the integration of Bluetooth® Low

EDEN PRAIRIE, MINNESOTA – Starkey has announced the promotion of industry veteran Hans Mehl to Chief Optimization Officer. With this promotion, Hans will continue to serve as an integral part of Starkey’s Executive Team and add to the company’s current trajectory of growth in 2024 and beyond. As Chief Optimization Officer, Mehl will play a crucial part in streamlining operations, enhancing

A new study published in JAMA Otolaryngology-Head & Neck Surgery suggests that a vestibular implant system may provide significant benefits for individuals suffering from bilateral vestibular hypofunction (BVH), a condition that impairs balance and spatial perception. The study examined outcomes from the Multichannel Vestibular Implant (MVI) system, an implanted device that aims to treat BVH by continuously providing artificial sensory

HAUPPAUGE, NEW YORK — Monica Dreger, the Global Head of Research at Airbnb, stands out for her intuitive approach and finely honed listening skills. With a background in behavioral psychology, Dreger’s career has been dedicated to understanding consumer behavior and strategic planning for major brands like Mattel, Nickelodeon, and Unilever. Despite her professional success, Dreger’s personal journey with hearing loss

MONTPELLIER, FRANCE —  Sensorion (FR0012596468 – ALSEN), a leading clinical-stage biotechnology company specializing in innovative therapies for hearing-related conditions, has announced the successful recruitment of the final participant in its Phase 2a clinical trial of SENS-401. This trial aims to evaluate the efficacy of SENS-401 in preserving residual hearing in adult patients undergoing cochlear implantation. Preserving Residual Hearing in Cochlear